FBLG

Conviction 48HealthcareScan · Mon, Aug 10, 2026

FBLG$0.9700-0.64%

ResistanceSupportVol 14

Vol MA14 161.35K

May 11May 28Jun 16Jul 6Jul 23Aug 10

FibroBiologics, Inc.PHARMACEUTICAL PREPARATIONSwww.fibrobiologics.com ↗

Price0.9700

Change-0.64%

Gap-0.04%

Rel volume1.13×

Avg volume135.34K

Avg $ vol114.85K

SMA 200.7954

SMA 500.8608

SMA 2000.6595

Price vs 50+12.68%

Price vs 200+47.08%

MA stackbullish

50/200 cross—

Supertrendup · 0.7482

RSI (14)62

MACD hist0.04

MACD crossbull · 5d

Stoch %K / %D73 / 77

ADX (14)23

+DI / −DI36 / 12

RSI divergence—

MACD divergence—

ATR %+8.29%

ADR %8.47%

52w high2.28

52w low0.1966

From 52w high-57.46%

Above 52w low+393.39%

New 52w highNo

SqueezeOff

Bollinger width53.57%

%B0.91

Donchian pos73.47%

Donchian high1.10

Donchian low0.6200

AVWAP (52w high)1.29

vs AVWAP high-24.91%

AVWAP (52w low)1.24

vs AVWAP low-22.04%

OBV trendFlat

Chaikin MF (20)-0.04

Today vs 20d1.13×

Avg vol (14d)161.35K

Avg vol (20d)135.34K

Avg $ vol (20d)114.85K

Market cap6.46M

RS 3m (vs SPY)-26.97%

RS 6m (vs SPY)+315.74%

RS line new highNo

Trend template6/8

Technical rank92.5

1 week+22.71%

1 month+5.81%

3 months-16.38%

6 months+285.38%

1 year+81.58%

YTD+304.34%

P/E-0.35

P/B1.39

P/S—

P/FCF-0.39

EPS-0.4200

Div yield—

ROE-402.20%

ROA-235.16%

Debt/Eq0.01

Current2.64

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-67.06%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value3M

Revenue—

Net income-4.12M

Gross profit—

Free cash flow-16.66M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out5.21M

Employees15

ListedWed, Jan 31, 2024

Free float50.73M

Float %76.3%

Short interest70.84K

Days to cover1.2d

Short volume40.5%

Squeeze score9 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction48 / 100

Pattern quality—

Tech rank92.5 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.04

Support0.6755

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in FBLG

All disclosures →

No recent disclosed trades by Congress in FBLG. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in FBLG · 4 buys

Insider	Side	Shares	Value	Traded	Filed
O'HEERON PETE CHIEF EXECUTIVE OFFICER · Stock Option (Right to Buy) · 2026-05-04	Grant	92.41K	$0	2026-05-04	2026-05-04
Khoja Hamid Chief Scientific Officer · Stock Option (Right to Buy) · 2026-05-04	Grant	61.61K	$0	2026-05-04	2026-05-04
Davis Jason Chief Financial Officer · Stock Option (Right to Buy) · 2026-05-04	Grant	61.61K	$0	2026-05-04	2026-05-04
GARCIA RUBEN A General Counsel · Stock Option (Right to Buy) · 2026-05-04	Grant	61.61K	$0	2026-05-04	2026-05-04

SEC filings

EDGAR filings in FBLG · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.